243 related articles for article (PubMed ID: 18508530)
21. Synthetic human antibodies and a strategy for protein engineering.
Winter G
FEBS Lett; 1998 Jun; 430(1-2):92-4. PubMed ID: 9678601
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapeutic potential of antibodies produced in plants.
Ma JK; Hein MB
Trends Biotechnol; 1995 Dec; 13(12):522-7. PubMed ID: 8595138
[TBL] [Abstract][Full Text] [Related]
23. Antibody engineering at the millennium.
Gavilondo JV; Larrick JW
Biotechniques; 2000 Jul; 29(1):128-32, 134-6, 138 passim. PubMed ID: 10907088
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of antibody production in plants for human therapeutic use.
Russell DA
Curr Top Microbiol Immunol; 1999; 240():119-38. PubMed ID: 10394718
[TBL] [Abstract][Full Text] [Related]
25. Optimization of humanized IgGs in glycoengineered Pichia pastoris.
Li H; Sethuraman N; Stadheim TA; Zha D; Prinz B; Ballew N; Bobrowicz P; Choi BK; Cook WJ; Cukan M; Houston-Cummings NR; Davidson R; Gong B; Hamilton SR; Hoopes JP; Jiang Y; Kim N; Mansfield R; Nett JH; Rios S; Strawbridge R; Wildt S; Gerngross TU
Nat Biotechnol; 2006 Feb; 24(2):210-5. PubMed ID: 16429149
[TBL] [Abstract][Full Text] [Related]
26. Alternative Eukaryotic Expression Systems for the Production of Proteins and Protein Complexes.
Gómez S; López-Estepa M; Fernández FJ; Suárez T; Vega MC
Adv Exp Med Biol; 2016; 896():167-84. PubMed ID: 27165325
[TBL] [Abstract][Full Text] [Related]
27. Antibody production by molecular farming in plants.
Fischer R; Hoffmann K; Schillberg S; Emans N
J Biol Regul Homeost Agents; 2000; 14(2):83-92. PubMed ID: 10841283
[TBL] [Abstract][Full Text] [Related]
28. Glycoprotein production in moss bioreactors.
Decker EL; Reski R
Plant Cell Rep; 2012 Mar; 31(3):453-60. PubMed ID: 21960098
[TBL] [Abstract][Full Text] [Related]
29. Plantibodies: applications, advantages and bottlenecks.
Stoger E; Sack M; Fischer R; Christou P
Curr Opin Biotechnol; 2002 Apr; 13(2):161-6. PubMed ID: 11950570
[TBL] [Abstract][Full Text] [Related]
30. Moss bioreactors producing improved biopharmaceuticals.
Decker EL; Reski R
Curr Opin Biotechnol; 2007 Oct; 18(5):393-8. PubMed ID: 17869503
[TBL] [Abstract][Full Text] [Related]
31. Engineering of glycosylation in yeast and other fungi: current state and perspectives.
De Pourcq K; De Schutter K; Callewaert N
Appl Microbiol Biotechnol; 2010 Aug; 87(5):1617-31. PubMed ID: 20585772
[TBL] [Abstract][Full Text] [Related]
32. Plant biopharming of monoclonal antibodies.
Ko K; Koprowski H
Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
[TBL] [Abstract][Full Text] [Related]
33. [Recent advances in the production of heterologous proteins in filamentous fungi].
Zhong Y; Wang X; Wang T
Sheng Wu Gong Cheng Xue Bao; 2008 Apr; 24(4):531-40. PubMed ID: 18616158
[TBL] [Abstract][Full Text] [Related]
34. Engineering the baculovirus genome to produce galactosylated antibodies in lepidopteran cells.
Juliant S; Lévêque M; Cérutti P; Ozil A; Choblet S; Violet ML; Slomianny MC; Harduin-Lepers A; Cérutti M
Methods Mol Biol; 2013; 988():59-77. PubMed ID: 23475714
[TBL] [Abstract][Full Text] [Related]
35. Versatile microbial surface-display for environmental remediation and biofuels production.
Wu CH; Mulchandani A; Chen W
Trends Microbiol; 2008 Apr; 16(4):181-8. PubMed ID: 18321708
[TBL] [Abstract][Full Text] [Related]
36. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates.
Vincent KJ; Zurini M
Biotechnol J; 2012 Dec; 7(12):1444-50. PubMed ID: 23125076
[TBL] [Abstract][Full Text] [Related]
37. Stability of protein production from recombinant mammalian cells.
Barnes LM; Bentley CM; Dickson AJ
Biotechnol Bioeng; 2003 Mar; 81(6):631-9. PubMed ID: 12529877
[TBL] [Abstract][Full Text] [Related]
38. In vitro antibodies: strategies for production and application.
Morrison SL
Annu Rev Immunol; 1992; 10():239-65. PubMed ID: 1590987
[TBL] [Abstract][Full Text] [Related]
39. The biotechnology and applications of antibody engineering.
Rapley R
Mol Biotechnol; 1995 Apr; 3(2):139-54. PubMed ID: 7620975
[TBL] [Abstract][Full Text] [Related]
40. Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans.
Hollister J; Grabenhorst E; Nimtz M; Conradt H; Jarvis DL
Biochemistry; 2002 Dec; 41(50):15093-104. PubMed ID: 12475259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
